HLA-A*31 as a marker of genetic susceptibility to sepsis
- PMID: 24553509
- PMCID: PMC4031872
- DOI: 10.5935/0103-507X.20130049
HLA-A*31 as a marker of genetic susceptibility to sepsis
Abstract
Objective: The HLA haplotype has been associated with many autoimmune diseases, but no associations have been described in sepsis. This study aims to investigate the HLA system as a possible marker of genetic sepsis susceptibility.
Methods: This is a prospective cohort study including patients admitted to an intensive care unit and healthy controls from a list of renal transplant donors. Patients with less 18 years of age; pregnant or HIV positive patients; those with metastatic malignancies or receiving chemotherapy; or with advanced liver disease; or with end-of-life conditions were excluded. The DNA was extracted from the whole blood and HLA haplotypes determined using MiliPlex® technology.
Results: From October 2010 to October 2012, 1,121 patients were included (1,078 kidney donors, 20 patients admitted with severe sepsis and 23 with septic shock). HLA-A*31 positive subjects had increased risk of developing sepsis (OR 2.36, 95%CI 1.26-5.35). Considering a p value <0.01, no other significant association was identified.
Conclusion: HLA-A*31 expression is associated to risk of developing sepsis.
Objetivo: Haplótipos do HLA têm sido associados a muitas doenças autoimunes, mas não foi descrita qualquer associação na sepse. O objetivo desse estudo é investigar o sistema HLA como um possível marcador de suscetibilidade genética à sepse.
Métodos: Estudo prospectivo de coorte, incluindo pacientes admitidos em unidade de terapia intensiva e controles-saudáveis obtidos em lista de doadores de transplante renal. Foram excluídos pacientes abaixo dos 18 anos de idade, gestantes ou HIV positivos, pacientes com doença maligna metastática ou sob quimioterapia, pacientes com hepatopatia avançada, com condições de fim de vida. O DNA foi extraído de sangue total, e a haplotipagem de HLA foi realizada com a tecnologia MiliPlex®.
Resultados: Foram incluídos 1.121 pacientes (1.078 doadores de rim, 20 pacientes com sepse grave e 23 pacientes admitidos por choque séptico) entre outubro de 2010 e outubro de 2012. Os participantes positivos para HLA-A*31 tiveram risco aumentado de desenvolver sepse (OR: 2,36 IC95%: 1,26-5,35). Não foi identificada outra associação significativa, quando considerado como nível de significância o valor de p<0,01.
Conclusão: A expressão de HLA-A*31 está associada ao risco de desenvolvimento de sepse.
Conflict of interest statement
Similar articles
-
HLA-A Locus is Associated With Sepsis and Septic Shock After Traumatic Injury.Ann Surg. 2022 Jan 1;275(1):203-207. doi: 10.1097/SLA.0000000000003932. Ann Surg. 2022. PMID: 33064392 Free PMC article.
-
TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre study.Genes Immun. 2004 Dec;5(8):631-40. doi: 10.1038/sj.gene.6364136. Genes Immun. 2004. PMID: 15526005
-
Association of HLA-G 3'UTR polymorphisms and haplotypes with severe sepsis in a Brazilian population.Hum Immunol. 2017 Nov;78(11-12):718-723. doi: 10.1016/j.humimm.2017.09.002. Epub 2017 Sep 21. Hum Immunol. 2017. PMID: 28941746
-
Genetic insights into sepsis: what have we learned and how will it help?Curr Pharm Des. 2008;14(19):1900-11. doi: 10.2174/138161208784980554. Curr Pharm Des. 2008. PMID: 18691101 Review.
-
Epigenetic biomarkers for human sepsis and septic shock: insights from immunosuppression.Epigenomics. 2020 Apr;12(7):617-646. doi: 10.2217/epi-2019-0329. Epub 2020 May 12. Epigenomics. 2020. PMID: 32396480 Review.
Cited by
-
Use of machine learning-based integration to develop a monocyte differentiation-related signature for improving prognosis in patients with sepsis.Mol Med. 2023 Mar 20;29(1):37. doi: 10.1186/s10020-023-00634-5. Mol Med. 2023. PMID: 36941583 Free PMC article.
-
Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update.Clin Pharmacol Ther. 2018 Apr;103(4):574-581. doi: 10.1002/cpt.1004. Epub 2018 Feb 2. Clin Pharmacol Ther. 2018. PMID: 29392710 Free PMC article.
References
-
- Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546–1554. - PubMed
-
- Cho JH, Gregersen PK. Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med. 2011;365(17):1612–1623. - PubMed
-
- Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet. 1973;1(7809):904–907. - PubMed
-
- Habek M, Brinar VV, Borovecki F. Genes associated with multiple sclerosis: 15 and counting. Expert Rev Mol Diagn. 2010;10(7):857–861. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials